Germany expects EU deal for BioNTech-Pfizer vaccine 'in the coming days'

© Reuters. Pfizer’s logo is reflected in a drop on a syringe needle in this illustration

BERLIN (Reuters) – German Health Minister Jens Spahn expects a final purchase agreement with BioNTech (O:) and its partner Pfizer (N:) to be signed “in the coming days” for its potential vaccine against COVID-19.

“We will now bring this to a speedy conclusion,” Spahn told a news conference in Berlin.

Spahn said he expects Germany will get up to 100 million doses of the BioNTech-Pfizer vaccine.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


READ  Treasury Committee to question BOE's Carney on Tuesday


Please enter your comment!
Please enter your name here